ANG-4201

N/A

Report date: 2022/01/14 13:23:58
NME

Base Information

Drug NameANG-4201
Drug Alias NameANG-4201
ClassificationSmall molecules
Mechanisms of ActionRho-associated protein kinase 2 inhibitors
TargetsRho-associated protein kinase 2
Therapy Area/IndicationsRenal fibrosis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesElicio Therapeutics
China Registration ClassN/A

Develop Information

Active CompaniesElicio Therapeutics
Inactive CompaniesN/A
Active IndicationsRenal fibrosis
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A